Chargement en cours...
Development of an Effective Therapy for CML
Targeted small molecule drugs have revolutionized treatment of chronic myeloid leukemia (CML) over the last decade. These agents interrupt a constitutively active BCR-ABL, the causative agent for CML, by interfering with ATP-dependent ABL tyrosine kinase. Although the efficacy of tyrosine kinase inh...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251313/ https://ncbi.nlm.nih.gov/pubmed/22157291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e318237e5b7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|